Drugs are nothing if not properly manufactured, and that includes lots and lots of in-process testing.
At the Cleveland Clinic, as ?Bottle of Lies? chronicles, he art transplant patients whose anti-rejection medication was working fine en ded up suffering organ rejection after taking an ineffective Indian-made im munosuppressant.
d lots of in-process testing.
heart transplant patients whose anti-rejection medication was working fine ended up suffering organ rejection after taking an ineffective Indian-made immunosuppressant.
I've always thought the loratadine (Claritin) that you can now buy over the counter from generic mfgrs isn't nearly as effective at relieving allergy/hay fever symptoms the name brand.
d lots of in-process testing.
heart transplant patients whose anti-rejection medication was working fine ended up suffering organ rejection after taking an ineffective Indian-made immunosuppressant.
What I take away from this is that the US is still in the same camp with 7% of forms inspected having "data manipulation", in other words falsified! While we are complaining about India and China, why are the US numbers so h igh? Is 50% violation rate acceptable in the US while 67% in China is not?
-- Rick C. - Get 1,000 miles of free Supercharging - Tesla referral code - https://ts.la/richard11209
Since they put the pseudoepinephrine-based drugs behind the counter or aren't available at all in some locations, studies have shown the phenylephrine hydrochloride-based cold meds are no more effective than placebo.
When I've tried that type of medication when I have a cold symptoms feel like 10% better at best
and lots of in-process testing.
, heart transplant patients whose anti-rejection medication was working fin e ended up suffering organ rejection after taking an ineffective Indian-mad e immunosuppressant.
7% of forms inspected having "data manipulation", in other words falsified! While we are complaining about India and China, why are the US numbers so high? Is 50% violation rate acceptable in the US while 67% in China is no t?It's the nature of the violation that is so much more important. The U.S. h as a 7% data manipulation rate. I attribute that to a low level manager who 's having problems meeting production schedules, and his/her actions are do ne on the sly unknown to higher ups. Whereas in Asia it's an entire organiz ational effort. Then the fact of the inspections in Asia being conducted on a pre-announced schedule means the real story is so much worse. The U.S. c an tighten up its problems with criminal penalties that really hurt these p eople But there is the problem of many manufacturers being the only produce r of that particular drug, which means shutting down the operation entirely is not an option. Right now we have this nightmare as an example, although no data integrity issues of record:
and lots of in-process testing.
, heart transplant patients whose anti-rejection medication was working fin e ended up suffering organ rejection after taking an ineffective Indian-mad e immunosuppressant.
Yep- those big box generics aren't worth saving a couple of bucks if they d on't work.
and lots of in-process testing.
s, heart transplant patients whose anti-rejection medication was working fi ne ended up suffering organ rejection after taking an ineffective Indian-ma de immunosuppressant.
/
That's like the recent semi-insane restrictions on opioids. I get that the se drugs are used for improper purposes, but does that justify making them unavailable for those who need to use them responsibly?
Why is it that we can't find ways to limit the misuse of drugs that doesn't harm others by making them unavailable?
-- Rick C. + Get 1,000 miles of free Supercharging + Tesla referral code - https://ts.la/richard11209
s and lots of in-process testing.
es, heart transplant patients whose anti-rejection medication was working f ine ended up suffering organ rejection after taking an ineffective Indian-m ade immunosuppressant.
h 7% of forms inspected having "data manipulation", in other words falsifie d! While we are complaining about India and China, why are the US numbers so high? Is 50% violation rate acceptable in the US while 67% in China is not?
has a 7% data manipulation rate. I attribute that to a low level manager w ho's having problems meeting production schedules, and his/her actions are done on the sly unknown to higher ups. Whereas in Asia it's an entire organ izational effort. Then the fact of the inspections in Asia being conducted on a pre-announced schedule means the real story is so much worse. The U.S. can tighten up its problems with criminal penalties that really hurt these people But there is the problem of many manufacturers being the only produ cer of that particular drug, which means shutting down the operation entire ly is not an option. Right now we have this nightmare as an example, althou gh no data integrity issues of record:
ren/story?id=66411784
So you make up some justification for the problem in the US only paying att ention to a single figure while ignoring the number that is scary, 49% of t he inspections in the US show problems!!! HALF!!! WTF!!!
If I got a ticket half the time I drove by a cop I would not have a license anymore.
I've read that there are 200,000 deaths each year in the US due to prescrip tion drug mistakes. Now we find a terrible safety record in the factories making the drugs.
-- Rick C. -- Get 1,000 miles of free Supercharging -- Tesla referral code - https://ts.la/richard11209
Tried nasal steroids? Flonase is OTC now.
-- John Larkin Highland Technology, Inc picosecond timing precision measurement jlarkin att highlandtechnology dott com http://www.highlandtechnology.com
ots and lots of in-process testing.
cles, heart transplant patients whose anti-rejection medication was working fine ended up suffering organ rejection after taking an ineffective Indian
-made immunosuppressant.
ith 7% of forms inspected having "data manipulation", in other words falsif ied! While we are complaining about India and China, why are the US number s so high? Is 50% violation rate acceptable in the US while 67% in China i s not?
S. has a 7% data manipulation rate. I attribute that to a low level manager who's having problems meeting production schedules, and his/her actions ar e done on the sly unknown to higher ups. Whereas in Asia it's an entire org anizational effort. Then the fact of the inspections in Asia being conducte d on a pre-announced schedule means the real story is so much worse. The U. S. can tighten up its problems with criminal penalties that really hurt the se people But there is the problem of many manufacturers being the only pro ducer of that particular drug, which means shutting down the operation enti rely is not an option. Right now we have this nightmare as an example, alth ough no data integrity issues of record:
ldren/story?id=66411784
ttention to a single figure while ignoring the number that is scary, 49% of the inspections in the US show problems!!! HALF!!! WTF!!!
se anymore.
iption drug mistakes. Now we find a terrible safety record in the factorie s making the drugs.
You don't know the nature of those violations, inspections can be very nitp icky. Spot analysis of product from U.S. operations has never revealed the kind of widespread crazy results they get for the Asian product, stuff like doses with no active ingredient at all.
lots and lots of in-process testing.
nicles, heart transplant patients whose anti-rejection medication was worki ng fine ended up suffering organ rejection after taking an ineffective Indi an-made immunosuppressant.
with 7% of forms inspected having "data manipulation", in other words fals ified! While we are complaining about India and China, why are the US numb ers so high? Is 50% violation rate acceptable in the US while 67% in China is not?
U.S. has a 7% data manipulation rate. I attribute that to a low level manag er who's having problems meeting production schedules, and his/her actions are done on the sly unknown to higher ups. Whereas in Asia it's an entire o rganizational effort. Then the fact of the inspections in Asia being conduc ted on a pre-announced schedule means the real story is so much worse. The U.S. can tighten up its problems with criminal penalties that really hurt t hese people But there is the problem of many manufacturers being the only p roducer of that particular drug, which means shutting down the operation en tirely is not an option. Right now we have this nightmare as an example, al though no data integrity issues of record:
attention to a single figure while ignoring the number that is scary, 49% of the inspections in the US show problems!!! HALF!!! WTF!!!
ense anymore.
cription drug mistakes. Now we find a terrible safety record in the factor ies making the drugs.
tpicky. Spot analysis of product from U.S. operations has never revealed th e kind of widespread crazy results they get for the Asian product, stuff li ke doses with no active ingredient at all.
Your report doesn't indicate any of that. Where did you read this addition al data?
My point is regardless of what the problems are in China and elsewhere, 50% is a failing grade here in the US. It isn't justified by pointing to othe r countries and saying we are so much better than them!
-- Rick C. -+ Get 1,000 miles of free Supercharging -+ Tesla referral code - https://ts.la/richard11209
lots and lots of in-process testing.
icles, heart transplant patients whose anti-rejection medication was work ing fine ended up suffering organ rejection after taking an ineffective I ndian-made immunosuppressant.
with 7% of forms inspected having "data manipulation", in other words fa lsified! While we are complaining about India and China, why are the US numbers so high? Is 50% violation rate acceptable in the US while 67% in China is not?
U.S. has a 7% data manipulation rate. I attribute that to a low level ma nager who's having problems meeting production schedules, and his/her act ions are done on the sly unknown to higher ups. Whereas in Asia it's an e ntire organizational effort. Then the fact of the inspections in Asia bei ng conducted on a pre-announced schedule means the real story is so much worse. The U.S. can tighten up its problems with criminal penalties that really hurt these people But there is the problem of many manufacturers b eing the only producer of that particular drug, which means shutting down the operation entirely is not an option. Right now we have this nightmar e as an example, although no data integrity issues of record:
ng attention to a single figure while ignoring the number that is scary,
49% of the inspections in the US show problems!!! HALF!!! WTF!!!icense anymore.
escription drug mistakes. Now we find a terrible safety record in the fa ctories making the drugs.
nitpicky. Spot analysis of product from U.S. operations has never reveal ed the kind of widespread crazy results they get for the Asian product, s tuff like doses with no active ingredient at all.
tional data?
50% is a failing grade here in the US. It isn't justified by pointing t o other countries and saying we are so much better than them!The joys of deregulation - more people die...
John :-#(#
Yeah that's next step. Spring allergies have gotten worse as I've gotten older also the pollen season in NE is much longer and heavier than it once was due to the climate change that isn't happening.
Whether name brand or generic Claritin it starts to lose effectiveness sooner or later if you take it every day, so probably need to "rotate the shields" and switch approaches after a while at least.
Another drug I've definitely noticed a quality difference is the sleeping med Ambien I've had to use occasionally due to e.g. needing to get some sleep while recovering at home after a surgery.
For me the 10 mg of the name brand standard release was rapid lights-out time. The 10 mg of the generic was hmm...maybe feel a little tired? not much happening...took about an hour to fall asleep with the made-in-India generic. Probably just fell asleep naturally, placebo
es lots and lots of in-process testing.
ronicles, heart transplant patients whose anti-rejection medication was wor king fine ended up suffering organ rejection after taking an ineffective In dian-made immunosuppressant.
mp with 7% of forms inspected having "data manipulation", in other words fa lsified! While we are complaining about India and China, why are the US nu mbers so high? Is 50% violation rate acceptable in the US while 67% in Chi na is not?
e U.S. has a 7% data manipulation rate. I attribute that to a low level man ager who's having problems meeting production schedules, and his/her action s are done on the sly unknown to higher ups. Whereas in Asia it's an entire organizational effort. Then the fact of the inspections in Asia being cond ucted on a pre-announced schedule means the real story is so much worse. Th e U.S. can tighten up its problems with criminal penalties that really hurt these people But there is the problem of many manufacturers being the only producer of that particular drug, which means shutting down the operation entirely is not an option. Right now we have this nightmare as an example, although no data integrity issues of record:
ng attention to a single figure while ignoring the number that is scary, 49 % of the inspections in the US show problems!!! HALF!!! WTF!!!
icense anymore.
escription drug mistakes. Now we find a terrible safety record in the fact ories making the drugs.
nitpicky. Spot analysis of product from U.S. operations has never revealed the kind of widespread crazy results they get for the Asian product, stuff like doses with no active ingredient at all.
onal data?
Do you have any idea of the concept of accumulated background knowledge fro m previous readings? Or is it all you know how to do is "gleam" information from what's set in front of you and take that as the totality of what ther e is to know about the subject?
0% is a failing grade here in the US. It isn't justified by pointing to ot her countries and saying we are so much better than them!
udes lots and lots of in-process testing.
chronicles, heart transplant patients whose anti-rejection medication was w orking fine ended up suffering organ rejection after taking an ineffective Indian-made immunosuppressant.
camp with 7% of forms inspected having "data manipulation", in other words falsified! While we are complaining about India and China, why are the US numbers so high? Is 50% violation rate acceptable in the US while 67% in C hina is not?
The U.S. has a 7% data manipulation rate. I attribute that to a low level m anager who's having problems meeting production schedules, and his/her acti ons are done on the sly unknown to higher ups. Whereas in Asia it's an enti re organizational effort. Then the fact of the inspections in Asia being co nducted on a pre-announced schedule means the real story is so much worse. The U.S. can tighten up its problems with criminal penalties that really hu rt these people But there is the problem of many manufacturers being the on ly producer of that particular drug, which means shutting down the operatio n entirely is not an option. Right now we have this nightmare as an example , although no data integrity issues of record:
ying attention to a single figure while ignoring the number that is scary,
49% of the inspections in the US show problems!!! HALF!!! WTF!!!license anymore.
prescription drug mistakes. Now we find a terrible safety record in the fa ctories making the drugs.
y nitpicky. Spot analysis of product from U.S. operations has never reveale d the kind of widespread crazy results they get for the Asian product, stuf f like doses with no active ingredient at all.
tional data?
rom previous readings? Or is it all you know how to do is "gleam" informati on from what's set in front of you and take that as the totality of what th ere is to know about the subject?
I asked you where you got your information and this is your reply. I expe cted there would be no credible source.
-- Rick C. +- Get 1,000 miles of free Supercharging +- Tesla referral code - https://ts.la/richard11209
I had some job interviews back east, but New Jersey is the ragweed capital of the world, and it would have been horrible.
A lot of allergens are man-made, not so much climate change as the way we manage the land.
Try Flonase. It takes a few days to kick in, but it really works.
-- John Larkin Highland Technology, Inc picosecond timing precision measurement jlarkin att highlandtechnology dott com http://www.highlandtechnology.com
ElectronDepot website is not affiliated with any of the manufacturers or service providers discussed here. All logos and trade names are the property of their respective owners.